The two-depth problem with single-wavelength light

Hold a torch against your palm and the glow spreads across your skin — but none of that light reaches the bones beneath. Shine a more powerful infrared source at the same hand and the surface barely registers it, yet deeper tissue begins to warm. This is not a flaw in either lamp; it is the physics of how different wavelengths interact with biological tissue.

Every photon that enters the body faces the same journey: it is scattered by collagen fibres, reflected by cell membranes, and absorbed by chromophores — light-sensitive molecules that vary in concentration from layer to layer. Red light, around 660 nm, is captured readily by chromophores in the dermis. It drives collagen signalling and fibroblast activity at the surface with real efficiency, but it rarely travels far enough to reach muscle, joint capsule, or deeper connective tissue. Near-infrared light at roughly 850 nm tells a different story: it slips past the melanin-rich surface layers that absorb so much of the visible spectrum and continues several centimetres into the body, where muscle, joint, and organ tissue sit.

The practical consequence is what might be called the two-depth problem: a single-wavelength session either serves the skin well or reaches deeper structures — but not both within the same exposure. Neither outcome alone covers the full tissue column a recovery or regeneration protocol might need.

This is the gap the CellLight™ Photon System was engineered around. The question the rest of this article answers is a precise one: why did Professor Paul Lee anchor the design to 660 nm and 850 nm delivered simultaneously, and what happens in the body when both wavelengths arrive together?

What 660 nm red light does at the surface

The dermal layer — roughly 1 to 4 mm beneath the skin surface — is where collagen scaffolding is synthesised, maintained, and remodelled. It is also the primary destination of 660 nm red light.

At this depth, the photons encounter two populations that matter most for connective-tissue resilience: fibroblasts, the cells responsible for producing collagen and the extracellular matrix; and the mitochondria within them. The Pod White Paper and independent peer-reviewed work both identify cytochrome c oxidase (CCO) — the terminal enzyme in the mitochondrial electron transport chain — as the dominant molecular target at this wavelength. CCO absorbs the incoming photons and converts that energy into elevated ATP output, triggering a downstream signalling cascade that research suggests may support collagen synthesis and fibroblast activity in tissue that is ageing, stressed, or recovering from load. The process is the same biological lever the CellLight system is designed to engage: mitochondrial photon absorption as a prompt for cellular energy production.

The dermal layer is also the zone where microvascular exchange begins. Capillary networks at this depth handle both nutrient delivery and metabolic waste removal; some PBM studies indicate that consistent red-light exposure may contribute to local circulatory signalling, with modest knock-on effects for tissue homeostasis.

The upshot is that 660 nm saturates the upper tissue column — the zone most relevant to skin quality and connective-tissue maintenance. CellLight is designed to support this layer as a wellness input: it is the surface half of a two-depth strategy, framed around collagen signalling and surface recovery, not as a clinical intervention for any skin condition.

What 850 nm near-infrared reaches that red light cannot

850 nm sits just beyond the visible spectrum — the eye registers almost none of it as brightness. This matters because the same surface chromophores and melanin that absorb so much red light interact far less with NIR, allowing it to travel several centimetres into muscle, joint capsule, and dense connective tissue: the load-bearing structures most implicated in recovery from training or the accumulated wear of ageing.

At that depth, the cellular target is the same as in the dermis — CCO — but the tissue context changes the stakes. Skeletal muscle and joint tissue carry high metabolic demand, especially after physical load or when inflammatory signalling is already active. NIR photons reaching these layers may prompt CCO to elevate ATP output in precisely the tissue where the energy deficit is largest. A 2025 study on synovial inflammation found that 810 nm PBM showed the most potent suppression of inflammatory gene expression in joint tissue across wavelengths tested, lending support to the idea that NIR's deeper reach carries particular relevance for musculoskeletal recovery.

Skin melanin is worth noting as a contextual variable: it modulates how much NIR energy crosses the surface. Monte Carlo simulations published in 2025 confirm that penetration depth is wavelength-dependent and linearly linked to optical power density, with melanin acting as a variable attenuator — part of why calibrated dosing matters rather than simply maximising intensity.

Both wavelengths, in short, speak the same cellular language through CCO. They simply knock on different doors.

Why simultaneous delivery outperforms alternating sessions

Running a red-light session on Monday and an NIR session on Thursday is not the same as receiving both on the same day. The gap matters because tissue repair is not a pause-and-resume process: the repair signal triggered on Monday begins to attenuate before Thursday arrives. Simultaneous delivery sidesteps this by saturating the full tissue column — dermis through deep muscle — within a single window, so collagen signalling and mitochondrial support in deeper structures occur together rather than in rotation.

Evidence for combining wavelengths rather than alternating them is still at the research stage, but the early findings point in a consistent direction. A 2025 study on dual near-infrared PBMT (pulsed 810 nm combined with superpulsed 904 nm) found that the combination reduced inflammation markers — NF-κB, TNF-α, IL-1β — and pain mediators including COX-2 significantly beyond what either wavelength achieved in isolation. The effect was described by the researchers as synergistic rather than merely additive: the paired wavelengths appeared to shift tissue biology in ways that neither could replicate alone. Separately, aggregate evidence from studies using 630 nm + 850 nm and 660 nm + 830 nm combinations suggests these pairings may yield superior collagen-boosting outcomes compared with equivalent single-wavelength protocols.

There is also a practical argument. A Pod session is time-bounded, and it integrates heat, vibration, and magnetic input alongside light. Compressing both wavelengths into one session preserves the time economy that makes the protocol sustainable across weeks; splitting them across separate sessions would double the time burden whilst breaking the coordinated physiological context in which all the modalities are designed to operate.

This logic — that inputs are more effective when they act on the body together than when they are scheduled in isolation — is central to the systemic thinking in Professor Paul Lee's Regeneration by Design. The two wavelengths are not redundant features; they are the mechanism by which CellLight addresses tissue as a layered structure rather than a surface.

Biphasic dosing and the Goldilocks Zone of photon density

Light follows a precise biological rule that applies to almost every cellular stimulus: too little produces no meaningful response; too much tips into stress. This is the Arndt-Schulz law — established in pharmacology in the nineteenth century and since confirmed across photobiomodulation research. Dose response is biphasic: efficacy rises with photon intensity to an optimum, then declines as thermal effects begin to suppress the CCO activation the light was meant to encourage.

CellLight is engineered around that optimum. Using both pulsed and continuous-wave emission, the system holds photon density within the narrow band that maximises CCO absorption without generating heat at the tissue surface. The Pod's design documentation shorthand calls this the 'Goldilocks Zone' — a label for the established biphasic sweet spot, not a proprietary invention. The use of two delivery modes (pulsed and continuous-wave) to hold that calibration steady is a deliberate engineering decision, reflecting the Medical Engineering rigour that Professor Paul Lee — who holds a PhD in Medical Engineering from Cardiff University — brings to the Pod's hardware design.

One honest boundary is worth stating plainly, because it is also a reason this calibration is particularly relevant to the 40-70+ audience the Pod is built for. Research suggests PBM's cellular repair signal is most detectable when biological function is already under strain — through ageing, post-exercise inflammation, or accumulated metabolic load. In healthy young subjects, some studies have found null or minimal effects, implying the photon stimulus registers loudest where the body has the most catching up to do. For those in midlife and beyond, that is less a caveat than a reason for relevance.

The R1 Synergy Chipset sequences the light dose alongside heat, vibration, and magnetic input within each session, ensuring photon delivery integrates into a coordinated protocol rather than operating in isolation.

CellLight in practice: session rhythm and the Physics pillar

Inside a Pod session, CellLight does not feel like a spotlight. The system distributes 660 nm and 850 nm across a full-body LED field, so both tissue depths receive simultaneous exposure across the whole surface — a design choice that distinguishes systemic coverage from point-treatment, and makes the kind of collagen signalling and mitochondrial support described in earlier sections available everywhere, not just where a panel happens to face.

Professor Paul Lee describes this in Practical Regeneration (FCM Publishing, February 2026) as delivering wavelengths that encourage mitochondria to produce energy more efficiently, expressed "through a broader and more evenly distributed full-body field." That phrasing captures something the wavelength science alone does not: the ambition is whole-system input rather than localised therapy. This is the Physics pillar of Regeneration by Design made tangible — the argument that physical energies, including photons, are not supplementary extras but fundamental inputs to biological repair. CellLight puts that into practice: two wavelengths, calibrated to the right density, delivered in the right session window alongside heat, vibration, and magnetic fields.

Consistency is the variable the evidence keeps returning to. Photobiomodulation responses are cumulative, which means the protocol is designed for once or twice weekly use, with meaningful adaptation typically taking shape from around six sessions onward. A single session is a stimulus; the sustained series is where the signal registers.

As with all the Pod's modalities, CellLight is a wellness tool rather than a medical device — designed to support recovery, energy, and long-term resilience, not to diagnose or treat any condition. For specific health concerns, a healthcare professional remains the right first conversation. What the Physics pillar asks of the body is simpler than that: are you giving it the physical inputs it needs, consistently, and in the right conditions? Two wavelengths, two depths, one coordinated session — CellLight's answer is precise because the question is.

1. [1] Photobiomodulation of Cytochrome c Oxidase by Chronic Transcranial Laser in Young and Aged Brains. (2022). https://doi.org/10.3389/fnins.2022.818005 https://doi.org/10.3389/fnins.2022.818005
2. [2] Therapeutic potential of wavelength-dependent photobiomodulation on gut inflammation in an in vitro intestinal model. (2025). https://doi.org/10.1016/j.jphotobiol.2025.113201 https://doi.org/10.1016/j.jphotobiol.2025.113201
3. [3] Wavelength-dependent photobiomodulation attenuates synovial inflammation in fibroblast-like synoviocytes and a collagenase-induced osteoarthritis model. (2025). https://doi.org/10.1016/j.jphotobiol.2025.113276 https://doi.org/10.1016/j.jphotobiol.2025.113276
4. [4] Simulation-based dosimetry of transcranial and intranasal photobiomodulation: roles of wavelength, power density, and skin tone. (2025). https://doi.org/10.1364/BOE.567345 https://doi.org/10.1364/BOE.567345
5. [5] Dual near-infrared wavelength photobiomodulation accelerates transdermal burn wound repair via anti-inflammatory, pain relief and redox-regulating mechanisms. (2025). https://doi.org/10.1016/j.jphotobiol.2025.113267 https://doi.org/10.1016/j.jphotobiol.2025.113267
6. [6] Photobiomodulation therapy ameliorates hyperglycemia and insulin resistance by activating cytochrome c oxidase-mediated protein kinase B in muscle. (2021). https://doi.org/10.18632/aging.202760 https://doi.org/10.18632/aging.202760